Remyelination varies between and within lesions in multiple sclerosis following bexarotene
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51662
Abstract: In multiple sclerosis chronic demyelination is associated with axonal loss, and ultimately contributes to irreversible progressive disability. Enhancing remyelination may slow, or even reverse, disability. We recently trialled bexarotene versus placebo in 49 people with… read more here.
Keywords: sclerosis; varies within; remyelination varies; multiple sclerosis ... See more keywords